Eric Sulpice

Title: Eric Sulpice: Innovator in Biomarker Screening and Nucleic Acid Transfection

Introduction

Eric Sulpice is a notable inventor based in Biviers, France. He has made significant contributions to the fields of biomarker identification and nucleic acid transfection. With a total of 2 patents, his work has the potential to impact medical research and therapeutic development.

Latest Patents

Eric Sulpice's latest patents include a high-throughput screening method for the identification of biomarkers, therapeutic targets, or therapeutic agents. This invention relates to a method for screening a molecule of interest using nanoparticles that comprise a candidate molecule, a tracer, and a single DNA tag specific to that molecule. Additionally, it addresses the screening of biomarkers for diseases, particularly cancer or infections, utilizing these nanoparticles. His second patent focuses on a method for the transfection of nucleic acids into eukaryotic cells within a 3D scaffold. This method involves contacting eukaryotic cells in a 3D scaffold with a nanoemulsion formulation that includes a continuous aqueous phase and at least one dispersed phase containing the nucleic acid.

Career Highlights

Throughout his career, Eric Sulpice has worked with prominent organizations, including the Commissariat à l'Énergie Atomique et aux Énergies Alternatives. His experience in these institutions has allowed him to develop innovative solutions in his field.

Collaborations

Eric has collaborated with notable colleagues such as Fabrice Navarro Y Garcia and Jonathan Bruniaux. These partnerships have contributed to the advancement of his research and inventions.

Conclusion

Eric Sulpice is a distinguished inventor whose work in biomarker screening and nucleic acid transfection showcases his innovative spirit and dedication to advancing medical science. His contributions are poised to make a lasting impact in the field.